Paracetamol (Acetaminophen) Explained

Paracetamol — known as acetaminophen in North America and Japan — is widely regarded as one of the most used medicines in the world. It appears on pharmacy shelves, hospital trolleys, and household first-aid kits across nearly every country, usually sold without a prescription for mild pain and fever. Its combination of broad availability, low cost, and a long safety record when used as directed has made it a cornerstone of everyday medicine. This article looks at how paracetamol came to be so ubiquitous, how it differs from related pain medicines, why it has two names, and how it is regulated globally.

This article does not provide dosing instructions or treatment advice. Always consult a healthcare professional or the medicine's package insert for guidance specific to your circumstances.

From coal tar to the medicine cabinet

Paracetamol's origins lie in the late nineteenth century, when chemists experimenting with coal tar derivatives produced compounds related to aniline, a chemical used in dyes. One of these, acetanilide, was found to reduce fever, and a related compound called phenacetin became a popular painkiller in the early twentieth century. Paracetamol — chemically N-acetyl-p-aminophenol — was identified as a breakdown product of phenacetin and was eventually recognised as having pain-relieving and fever-reducing properties of its own, with a more favourable safety profile than some of its predecessors.

Paracetamol was first marketed in the 1950s and gained widespread use over the following decades. By the 1970s it had largely replaced phenacetin, which was linked to kidney damage with long-term use. Today, paracetamol is included on the WHO Model List of Essential Medicines, reflecting its importance in basic healthcare systems worldwide.

Paracetamol and NSAIDs: different mechanisms

Paracetamol is often mentioned alongside non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, aspirin, and naproxen, because all are commonly used for mild to moderate pain and fever. However, paracetamol is not technically an NSAID. The main distinction is that NSAIDs reduce inflammation by inhibiting cyclo-oxygenase (COX) enzymes throughout the body, which is why they can ease swollen, inflamed tissues. Paracetamol's exact mechanism is still not fully understood, but it is generally believed to act mainly within the central nervous system and to have little anti-inflammatory effect in peripheral tissues.

This difference has practical consequences. NSAIDs are more commonly associated with gastrointestinal irritation, effects on kidney function, and effects on blood clotting. Paracetamol, by contrast, is less likely to irritate the stomach at standard doses, which is one reason it is so widely used by people who cannot tolerate NSAIDs. The key safety concern with paracetamol is the liver: taking more than the recommended total daily amount can cause serious liver damage, because the drug is metabolised by the liver. This risk underpins regulatory limits on pack sizes and warning labels in many countries.

Why two names for the same molecule?

The substance has two common names because of different historical naming conventions. "Paracetamol" is the name used in the United Kingdom, South Africa, Australia, New Zealand, and much of Europe and the Commonwealth; it is a contraction of the chemical name para-acetylaminophenol. "Acetaminophen" is used in the United States, Canada, and Japan, and is likewise a contraction of N-acetyl-p-aminophenol. Both names refer to exactly the same molecule. The World Health Organization's recommended international nonproprietary name (INN) is paracetamol, while the United States Adopted Name is acetaminophen.

This naming split can cause genuine confusion. Travellers may not recognise the local name for the medicine they use at home, and some people have accidentally taken more than intended by using both a "paracetamol" product and an "acetaminophen" product — a particular risk with multi-ingredient cold and flu remedies. Pharmacists and regulators generally advise patients to check the active ingredient name on the packaging rather than relying on the brand name alone.

Regulatory status and generic availability

Paracetamol is registered for sale in essentially every country with a medicines regulatory authority. In most jurisdictions it is available without a prescription, though the exact schedule classification varies — some countries restrict larger pack sizes or stronger formulations to pharmacy-only sales. In South Africa, paracetamol products are registered with SAHPRA and are widely available as both branded and generic versions; the Single Exit Price framework applies to pharmacy-channel products. You can search registered paracetamol products and compare prices using HealthSA.

Because paracetamol has been off-patent for decades, generic and branded-generic versions are manufactured by hundreds of companies worldwide. This abundance of producers is one reason the medicine is inexpensive and widely accessible. It is sold as a single-ingredient tablet, capsule, syrup, and suppository, and in combination with other actives such as codeine, caffeine, antihistamines, and decongestants. Most regulators require paracetamol products to carry warnings about liver risks, and several countries have introduced pack-size limits specifically to reduce the risk of intentional overdose. The US Food and Drug Administration, the European Medicines Agency, and SAHPRA all include paracetamol in their ongoing safety monitoring for liver-related adverse events.